What is Levy Konigsberg?
Levy Konigsberg LLP operates as a premier trial attorney firm with a nearly four-decade track record of securing justice in high-stakes environments. The firm specializes in complex litigation, including pharmaceutical liability, lead poisoning, and mesothelioma cases, while maintaining a strong focus on public health advocacy. Their market position is defined by a history of landmark victories, such as their involvement in the Flint Water Crisis and litigation against major multinational corporations. With over $3 billion recovered for clients, the firm serves as a critical intermediary between individuals seeking accountability and the entities responsible for systemic harm, effectively blending legal expertise with a mission-driven approach to public health reform.
How much funding has Levy Konigsberg raised?
Levy Konigsberg has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in Levy Konigsberg
PPP
Public-Private Partnership
What's next for Levy Konigsberg?
With the recent influx of capital, Levy Konigsberg is well-positioned to expand its reach into emerging areas of mass tort litigation and pharmaceutical liability. The firm is expected to leverage this financial backing to enhance its investigative infrastructure and trial support systems, ensuring that it remains at the forefront of complex legal challenges. As the firm continues to navigate the evolving regulatory and corporate landscape, this strategic investment will likely facilitate the pursuit of more aggressive litigation strategies, further cementing its reputation as a leader in protecting individual rights against institutional negligence. Future growth will likely focus on scaling its legal team and integrating advanced data analytics to streamline case management and improve outcomes for clients nationwide.
See full Levy Konigsberg company page
